BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 45 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,949,047 | -37.8% | 551,634 | -29.2% | 0.01% | -36.4% |
| Q2 2023 | $12,788,143 | -4.5% | 778,815 | -2.8% | 0.01% | -8.3% |
| Q1 2023 | $13,388,051 | +2.7% | 801,200 | -5.2% | 0.01% | 0.0% |
| Q4 2022 | $13,036,962 | -8.2% | 844,910 | -11.1% | 0.01% | -14.3% |
| Q3 2022 | $14,195,000 | -25.2% | 950,797 | -17.7% | 0.01% | -26.3% |
| Q2 2022 | $18,983,000 | -9.0% | 1,155,379 | +11.2% | 0.02% | +5.6% |
| Q1 2022 | $20,851,000 | +1.6% | 1,039,421 | +28.4% | 0.02% | +5.9% |
| Q4 2021 | $20,521,000 | -12.9% | 809,205 | -7.4% | 0.02% | -19.0% |
| Q3 2021 | $23,570,000 | -7.5% | 873,626 | -0.9% | 0.02% | -8.7% |
| Q2 2021 | $25,483,000 | +11.0% | 881,139 | +1.0% | 0.02% | 0.0% |
| Q1 2021 | $22,948,000 | +23.5% | 872,533 | +34.5% | 0.02% | +15.0% |
| Q4 2020 | $18,586,000 | +18.0% | 648,715 | -1.8% | 0.02% | 0.0% |
| Q3 2020 | $15,753,000 | +21.4% | 660,490 | +6.4% | 0.02% | +17.6% |
| Q2 2020 | $12,977,000 | +27.1% | 620,629 | +8.8% | 0.02% | +6.2% |
| Q1 2020 | $10,207,000 | – | 570,215 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |